Skip to main content
User account menu
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Nurses and AHPs
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Symposia - International Liver Congress
Industry Symposia - Digital Liver Cancer Summit 2021
Industry Symposia - Liver Cancer Summit 2022
Intercept - Primary Biliary Cholangitis: Clinical management
Online Course - NASH: From pathogenesis to non-invasive testing
See all EASL Studio Episodes
EASL Studio S2 E18: How can our response to the climate crisis transform and improve hepatology services?
June 29, 2022
EASL Studio S2 E17: EASL Haemochromatosis Guidelines 2022
June 15, 2022
EASL Studio S2 E16: The NAFLD pandemic
June 8, 2022
EASL Studio S2 E15: JHEP Live on the best animal model for HCC – Lost in translation?
June 1, 2022
EASL Studio S2 E14: Elastography – The new non-invasive gold standard in portal hypertension?
May 25, 2022
EASL Studio S2 E13: Digital Pathology
May 18, 2022
EASL Studio S2 E12: Nurse and AHP Focus: Sustainable hepatology – Insights in nursing initiatives
May 11, 2022
EASL Studio S2 E11: JHEP Live: Stop Nuc in HBeAg negative patients
May 4, 2022
EASL Studio S2 E10: LITMUS: Defining the colour of NAFLD
April 27, 2022
EASL Studio S2 E9: YI Choice: Propelling liver cell biology into the third dimension
April 20, 2022
EASL Studio S2 E8: Treatment of HBV-HDV coinfection in the era of entry inhibition
April 13, 2022
EASL Studio S2 E7: JHEP Live on critical appraisal of classification, diagnosis and treatment of hepatic encephalopathy
April 6, 2022
EASL Studio S2 E6: Should anticoagulants be given to patients with cirrhosis to improve outcome?
March 30, 2022
EASL Studio S2 E5: New era for science dissemination: The role of social media
March 23, 2022
EASL Studio S2 E4: Betablockers in cirrhosis: Has Baveno consensus gone too far?
March 16, 2022
EASL Studio S2 E3: Interview with Stephan Urban - From bench to bedside: Process of developing the first HBV/HDV entry inhibitor
March 9, 2022
EASL Studio S2 E2: Fats or carbs, who is the real villain?
March 2, 2022
EASL Studio S2 E1: New treatment options for hereditary cholestasis syndromes: A game-changer?
February 23, 2022